Literature DB >> 1393772

Decrease in bone level of 1,25-dihydroxyvitamin D in women over 45 years old.

P Sagiv1, C Lidor, T Hallel, S Edelstein.   

Abstract

The most active metabolite of vitamin D is 1,25-dihydroxyvitamin D [1,25(OH)2D]. Its level in the bone may play a role in the pathogenesis of metabolic bone diseases such as osteoporosis. To assess this, and to see whether there is correlation between serum and bone levels, we studied serum and bone samples taken from 43 patients (18 men and 25 women) undergoing different orthopedic procedures. Patients were studied according to sex and age groups (less than 45 years, 46-60 years, greater than 61 years). Serum level of 1,25(OH)2D was found to be 29.7 +/- 2.61 pg/ml (mean +/- SEM) for women, 32.2 +/- 3.86 pg/ml for men, and 30.7 +/- 2.18 pg/ml for the group as a whole. No significant statistical differences were found among age subgroups in either sex or between sexes. Bone level of 1,25(OH)2D was found to be 31.5 +/- 4.46 pg/g for women, 26.5 +/- 3.06 pg/g for men, and 29.4 +/- 2.81 pg/g for the entire group. No significant statistical difference was found between the age subgroups for men. However, the level of 1,25(OH)2D was found to be higher in the group of younger women (less than 45 years) compared with the older women (46-60 years and greater than 61 years) (P less than 0.005).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1393772     DOI: 10.1007/bf00296212

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  21 in total

1.  A sensitive, precise, and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma.

Authors:  J A Eisman; A J Hamstra; B E Kream; H F DeLuca
Journal:  Arch Biochem Biophys       Date:  1976-09       Impact factor: 4.013

2.  Influence of 1,25-hydroxyvitamin D3 on cytosolic free calcium concentrations.

Authors:  S Bar; C Lidor; A Harell; S Edelstein
Journal:  Biochem Biophys Res Commun       Date:  1986-12-30       Impact factor: 3.575

Review 3.  Extra-endocrine functions of vitamin D.

Authors:  I P Braidman; D C Anderson
Journal:  Clin Endocrinol (Oxf)       Date:  1985-10       Impact factor: 3.478

4.  Serum and bone vitamin D metabolites in elective patients and patients after fracture.

Authors:  D Alkalay; S Shany; S Dekel
Journal:  J Bone Joint Surg Br       Date:  1989-01

5.  Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium.

Authors:  J C Gallagher; B L Riggs; J Eisman; A Hamstra; S B Arnaud; H F DeLuca
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

6.  Effect of age on calcium absorption.

Authors:  J R Bullamore; R Wilkinson; J C Gallagher; B E Nordin; D H Marshall
Journal:  Lancet       Date:  1970-09-12       Impact factor: 79.321

Review 7.  Vitamin D metabolism and calcium absorption.

Authors:  A W Norman
Journal:  Am J Med       Date:  1979-12       Impact factor: 4.965

8.  The hormonal form of vitamin D in the pathophysiology and therapy of postmenopausal osteoporosis.

Authors:  A Caniggia; R Nuti; F Loré; A Vattimo
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

9.  Calcitriol in the treatment of postmenopausal osteoporosis.

Authors:  J F Aloia; A Vaswani; J K Yeh; K Ellis; S Yasumura; S H Cohn
Journal:  Am J Med       Date:  1988-03       Impact factor: 4.965

10.  Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients.

Authors:  D M Slovik; J S Adams; R M Neer; M F Holick; J T Potts
Journal:  N Engl J Med       Date:  1981-08-13       Impact factor: 91.245

View more
  5 in total

1.  Lack of in vitro evidence for storage of 1,25-dihydroxycholecalciferol (1,25(OH)2D3) and 1,25(OH)2D3 binding protein in skeletal matrix.

Authors:  S Boonen; J Aerssens; I Jans; E Van Herck; I Vandewal; J Peeters; R Van den Eynde; J Dequeker; R Bouillon
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

Review 2.  Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis.

Authors:  K L Dechant; K L Goa
Journal:  Drugs Aging       Date:  1994-10       Impact factor: 3.923

3.  Relations between calcidiol serum levels and bone mineral density in postmenopausal women with low bone density.

Authors:  M E Martínez; M T del Campo; M J Sánchez-Cabezudo; J A Garcia; M T Sánchez Calvín; A Torrijos; J Coya; L Munuera
Journal:  Calcif Tissue Int       Date:  1994-10       Impact factor: 4.333

4.  Decrease in bone levels of 1,25-dihydroxyvitamin D in women with subcapital fracture of the femur.

Authors:  C Lidor; P Sagiv; B Amdur; R Gepstein; I Otremski; T Hallel; S Edelstein
Journal:  Calcif Tissue Int       Date:  1993-02       Impact factor: 4.333

5.  Vitamin D metabolism: new concepts and clinical implications.

Authors:  P H Anderson; B K May; H A Morris
Journal:  Clin Biochem Rev       Date:  2003
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.